Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
DBMD Disease Information


Cryptococcosis

Navigation bar

 
 
Clinical Features Initial pulmonary infection is usually asymptomatic. Most patients present with disseminated infection, especially meningoencephalitis. In the United States, 85% of cases occur in HIV-infected persons.
Etiologic Agent Cryptococcus neoformans.
Reservoir C. neoformans var. neoformans has been isolated from the soil worldwide, usually in association with bird droppings. Less common etiologic agent, C. neoformans var. gattii has been isolated from eucalyptus trees in tropical and sub-tropical regions.
Incidence 0.4-1.3 cases per 100,000 in the general population. Among persons with AIDS, the annual incidence is 2-7 cases per 1,000.
Sequelae Meningitis may lead to permanent neurologic damage. Mortality rate is about 12%.
Transmission Inhalation of airborne yeast cells and/or basidiospores.
Risk Groups Immunocompromised persons, especially those with HIV infection.
Surveillance Active, population-based surveillance in selected U.S. sites. No national surveillance exists.
Challenges Developing a cost-effective prevention strategy (although fluconazole is effective chemoprophylaxis for persons with AIDS, it does not affect survival and is not considered cost-effective).

December 2003

 
 
 

Disease Listing | General Information | Technical Information | Additional Information
   
         

Accessibility | Privacy Policy Notice | FOIA

CDC Home | Search | Health Topics A-Z

This page last reviewed February 6, 2004

Centers for Disease Control and Prevention
National Center for Infectious Diseases
Division of Bacterial and Mycotic Diseases


 
Return to DBMD disease listing go to Additional Information